155 related articles for article (PubMed ID: 11803863)
1. [Our experience in the treatment of climacteric complaints with Livial (Organon)].
Pekhlivanov B; Malinova M; Milchev N
Akush Ginekol (Sofiia); 2001; 40(4):16-7. PubMed ID: 11803863
[TBL] [Abstract][Full Text] [Related]
2. Tibolone relieves climacteric symptoms in highly symptomatic women with at least seven hot flushes and sweats per day.
Landgren MB; Helmond FA; Engelen S
Maturitas; 2005 Mar; 50(3):222-30. PubMed ID: 15734603
[TBL] [Abstract][Full Text] [Related]
3. Livial: a review of clinical studies.
Moore RA
Br J Obstet Gynaecol; 1999 Mar; 106 Suppl 19():1-21. PubMed ID: 10890791
[No Abstract] [Full Text] [Related]
4. Efficacy and safety of oral tibolone 1.25 or 2.5 mg/day vs. placebo in postmenopausal women.
Hudita D; Posea C; Ceausu I; Rusu M
Eur Rev Med Pharmacol Sci; 2003; 7(5):117-25. PubMed ID: 15214586
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation on the compliance of livial therapy in peri and postmenopausal women].
Bai W; Yang X; Wang Y
Zhonghua Fu Chan Ke Za Zhi; 2000 Apr; 35(4):219-21. PubMed ID: 11776164
[TBL] [Abstract][Full Text] [Related]
6. The effect of a novel vaginal ring delivering oestradiol acetate on climacteric symptoms in postmenopausal women.
Buckler H; Al-Azzawi F;
BJOG; 2003 Aug; 110(8):753-9. PubMed ID: 12892687
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of a special extract of Rheum rhaponticum (ERr 731) in perimenopausal women with climacteric complaints: a 12-week randomized, double-blind, placebo-controlled trial.
Heger M; Ventskovskiy BM; Borzenko I; Kneis KC; Rettenberger R; Kaszkin-Bettag M; Heger PW
Menopause; 2006; 13(5):744-59. PubMed ID: 16894335
[TBL] [Abstract][Full Text] [Related]
8. [A preliminary report on the treatment of climacteric symptoms with Org OD14].
Wu YY
Zhonghua Fu Chan Ke Za Zhi; 1993 Sep; 28(9):539-41, 569-70. PubMed ID: 8313747
[TBL] [Abstract][Full Text] [Related]
9. Tibolone versus conjugated estrogens and sequential progestogen in the treatment of climacteric complaints.
Egarter C; Huber J; Leikermoser R; Haidbauer R; Pusch H; Fischl F; Putz M
Maturitas; 1996 Feb; 23(1):55-62. PubMed ID: 8861087
[TBL] [Abstract][Full Text] [Related]
10. The influence of tibolone on quality of life in postmenopausal women.
Meeuwsen IB; Samson MM; Duursma SA; Verhaar HJ
Maturitas; 2002 Jan; 41(1):35-43. PubMed ID: 11809341
[TBL] [Abstract][Full Text] [Related]
11. Dose-response analysis of effects of tibolone on climacteric symptoms.
Landgren MB; Bennink HJ; Helmond FA; Engelen S
BJOG; 2002 Oct; 109(10):1109-14. PubMed ID: 12387462
[TBL] [Abstract][Full Text] [Related]
12. New steroid for the climacteric syndrome.
Kicovic PM
Minerva Endocrinol; 1989; 14(1):63-7. PubMed ID: 2659954
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of Org OD 14 in the treatment of climacteric complaints.
Trévoux R; Dieulangard P; Blum A
Maturitas; 1983 Aug; 5(2):89-96. PubMed ID: 6633272
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of Pueraria mirifica (Kwao Kruea Khao) for the treatment of vasomotor symptoms in perimenopausal women: Phase II Study.
Lamlertkittikul S; Chandeying V
J Med Assoc Thai; 2004 Jan; 87(1):33-40. PubMed ID: 14971532
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of estradiol 1 mg and drospirenone 2 mg in postmenopausal Korean women: a double-blind, randomized, placebo-controlled, multicenter study.
Lee BS; Kang BM; Yoon BK; Choi H; Park HM; Kim JG
Maturitas; 2007 Aug; 57(4):361-9. PubMed ID: 17467203
[TBL] [Abstract][Full Text] [Related]
16. [Tibolone--a new steroid for therapy of the climacteric syndrome and prevention of osteoporosis].
Presl J
Cesk Gynekol; 1991 May; 56(4):299-301. PubMed ID: 1913870
[No Abstract] [Full Text] [Related]
17. Clinical experience with tibolone (Livial) over 8 years.
Ginsburg J; Prelevic G; Butler D; Okolo S
Maturitas; 1995 Jan; 21(1):71-6. PubMed ID: 7731388
[TBL] [Abstract][Full Text] [Related]
18. A randomized, open-label study of conjugated equine estrogens plus medroxyprogesterone acetate versus tibolone: effects on symptom control, bleeding pattern, lipid profile and tolerability.
Baracat EC; Barbosa IC; Giordano MG; Haidar MA; Marinho RM; Menegocci JC; Morais KM; Tomaz G; Wehba S
Climacteric; 2002 Mar; 5(1):60-9. PubMed ID: 11974560
[TBL] [Abstract][Full Text] [Related]
19. Hot flashes and sleep in women.
Moe KE
Sleep Med Rev; 2004 Dec; 8(6):487-97. PubMed ID: 15556380
[TBL] [Abstract][Full Text] [Related]
20. A case of diabetes following tibolone therapy.
Konstantopoulos K; Adamides S
Maturitas; 1994 May; 19(1):77-8. PubMed ID: 7935035
[No Abstract] [Full Text] [Related]
[Next] [New Search]
